Phase-one drug trials under scrutiny

18 January 2016

Carl Heneghan, Senior Tutor and Professor of Evidence-based Medicine, has said phase-one trials posed “significant practical and ethical issues” in an article for the Financial Times, covering a drug trial accident in France, which has left one dead and five in a stable condition in hospital. Carl Heneghan added, “With the increasing number of novel agents being tested, the current disaster highlights the need for regulators to be extremely vigilant; to ensure correct scientific procedures are adhered to at all times.” Read the full article.